ES420325A1 - Un procedimiento para preparar una prostaglandina. - Google Patents
Un procedimiento para preparar una prostaglandina.Info
- Publication number
- ES420325A1 ES420325A1 ES420325A ES420325A ES420325A1 ES 420325 A1 ES420325 A1 ES 420325A1 ES 420325 A ES420325 A ES 420325A ES 420325 A ES420325 A ES 420325A ES 420325 A1 ES420325 A1 ES 420325A1
- Authority
- ES
- Spain
- Prior art keywords
- carbon atoms
- phenyl
- see formula
- ligation
- substituent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30481372A | 1972-11-08 | 1972-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES420325A1 true ES420325A1 (es) | 1976-04-16 |
Family
ID=23178133
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES420325A Expired ES420325A1 (es) | 1972-11-08 | 1973-11-07 | Un procedimiento para preparar una prostaglandina. |
| ES433047A Expired ES433047A1 (es) | 1972-11-08 | 1974-12-18 | Un procedimiento para preparar productos intermedios de prostaglandinas. |
| ES433046A Expired ES433046A1 (es) | 1972-11-08 | 1974-12-18 | Un procedimiento para preparar productos intermedios de prostaglandinas. |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES433047A Expired ES433047A1 (es) | 1972-11-08 | 1974-12-18 | Un procedimiento para preparar productos intermedios de prostaglandinas. |
| ES433046A Expired ES433046A1 (es) | 1972-11-08 | 1974-12-18 | Un procedimiento para preparar productos intermedios de prostaglandinas. |
Country Status (29)
| Country | Link |
|---|---|
| JP (3) | JPS5416491B2 (OSRAM) |
| AR (3) | AR200585A1 (OSRAM) |
| AT (3) | AT367034B (OSRAM) |
| AU (1) | AU470375B2 (OSRAM) |
| BE (1) | BE806995A (OSRAM) |
| CA (3) | CA1085831A (OSRAM) |
| CH (1) | CH597176A5 (OSRAM) |
| CS (3) | CS182791B2 (OSRAM) |
| DD (4) | DD118856A5 (OSRAM) |
| DE (1) | DE2355540C2 (OSRAM) |
| DK (1) | DK144247C (OSRAM) |
| ES (3) | ES420325A1 (OSRAM) |
| FI (1) | FI60389C (OSRAM) |
| FR (3) | FR2205335B1 (OSRAM) |
| GB (3) | GB1456512A (OSRAM) |
| HK (3) | HK28079A (OSRAM) |
| HU (3) | HU172703B (OSRAM) |
| IE (1) | IE39537B1 (OSRAM) |
| IL (1) | IL43589A (OSRAM) |
| IN (1) | IN139384B (OSRAM) |
| KE (3) | KE2930A (OSRAM) |
| MY (3) | MY7900246A (OSRAM) |
| NL (1) | NL164273C (OSRAM) |
| NO (3) | NO147836C (OSRAM) |
| PH (3) | PH13272A (OSRAM) |
| SE (4) | SE448992B (OSRAM) |
| SU (4) | SU584766A3 (OSRAM) |
| YU (3) | YU39715B (OSRAM) |
| ZA (1) | ZA738554B (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3929862A (en) * | 1974-01-08 | 1975-12-30 | Upjohn Co | Substituted tolylesters of PGF{HD 2{B {60 |
| US3986764A (en) * | 1975-03-31 | 1976-10-19 | Gte Automatic Electric Laboratories Incorporated | Panel for supporting a pair of elongated mating connectors and selectively locking them together |
| GB1506817A (en) * | 1975-03-31 | 1978-04-12 | Upjohn Co | Prostaglandins |
| ES449162A1 (es) * | 1975-06-23 | 1977-12-16 | Syntex Inc | Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico. |
| GB1516414A (en) * | 1975-08-22 | 1978-07-05 | Ici Ltd | Prostane derivatives |
| SE7809008L (sv) * | 1977-12-12 | 1979-06-13 | Upjohn Co | Anvendning av amider av prostaglandintyp for att styra eller reglera reproduktionscykeln hos individer tillhorande deggdjursarter |
| IN150279B (OSRAM) * | 1978-01-16 | 1982-09-04 | Pfizer | |
| SK3382000A3 (en) * | 1997-09-09 | 2000-10-09 | Procter & Gamble | A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders |
| CA2364948C (en) | 1999-03-05 | 2011-04-26 | Duke University | C16 unsaturated fp-selective prostaglandins analogs |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| JP2002329615A (ja) * | 2001-05-02 | 2002-11-15 | Ohira Denshi Kk | トロイダルコイル |
| US6476064B1 (en) * | 2001-06-13 | 2002-11-05 | Allergan, Inc. | Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents |
| US20060135609A1 (en) | 2004-10-21 | 2006-06-22 | Duke University | Ophthamological drugs |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1324737A (en) * | 1970-11-02 | 1973-07-25 | Upjohn Co | Prostaglandins and the preparation thereof |
| IE37602B1 (en) * | 1971-05-11 | 1977-08-31 | Ici Ltd | Cyclopentane derivatives |
-
1972
- 1972-11-07 DD DD182498*A patent/DD118856A5/xx unknown
-
1973
- 1973-10-29 SE SE7314686A patent/SE448992B/xx unknown
- 1973-11-07 IL IL43589A patent/IL43589A/en unknown
- 1973-11-07 ES ES420325A patent/ES420325A1/es not_active Expired
- 1973-11-07 GB GB5175873A patent/GB1456512A/en not_active Expired
- 1973-11-07 GB GB2285876A patent/GB1456514A/en not_active Expired
- 1973-11-07 DD DD174504A patent/DD109212A5/xx unknown
- 1973-11-07 JP JP12527273A patent/JPS5416491B2/ja not_active Expired
- 1973-11-07 ZA ZA738554A patent/ZA738554B/xx unknown
- 1973-11-07 AT AT0936973A patent/AT367034B/de not_active IP Right Cessation
- 1973-11-07 IE IE2002/73A patent/IE39537B1/xx unknown
- 1973-11-07 DK DK601073A patent/DK144247C/da not_active IP Right Cessation
- 1973-11-07 DD DD182497*A patent/DD117233A5/xx unknown
- 1973-11-07 PH PH15191A patent/PH13272A/en unknown
- 1973-11-07 AR AR250885A patent/AR200585A1/es active
- 1973-11-07 BE BE1005485A patent/BE806995A/xx not_active IP Right Cessation
- 1973-11-07 IN IN2448/CAL/73A patent/IN139384B/en unknown
- 1973-11-07 CA CA185,274A patent/CA1085831A/en not_active Expired
- 1973-11-07 YU YU2880/73A patent/YU39715B/xx unknown
- 1973-11-07 NO NO4288/73A patent/NO147836C/no unknown
- 1973-11-07 GB GB2395076A patent/GB1456513A/en not_active Expired
- 1973-11-07 DE DE2355540A patent/DE2355540C2/de not_active Expired
- 1973-11-07 NL NL7315263.A patent/NL164273C/xx not_active IP Right Cessation
- 1973-11-07 AU AU62247/73A patent/AU470375B2/en not_active Expired
- 1973-11-07 DD DD182499*A patent/DD119411A5/xx unknown
- 1973-11-07 FI FI3443/73A patent/FI60389C/fi active
- 1973-11-07 CH CH1563973A patent/CH597176A5/xx not_active IP Right Cessation
- 1973-11-07 FR FR7339544A patent/FR2205335B1/fr not_active Expired
- 1973-11-08 HU HU72PI00000399A patent/HU172703B/hu unknown
- 1973-11-08 CS CS7300007669A patent/CS182791B2/cs unknown
- 1973-11-08 HU HU73PI00000452A patent/HU171819B/hu unknown
- 1973-11-08 CS CS7500006066A patent/CS182794B2/cs unknown
- 1973-11-08 CS CS7500006065A patent/CS182793B2/cs unknown
- 1973-11-08 HU HU73PI451A patent/HU173507B/hu unknown
- 1973-11-11 SU SU7301971722A patent/SU584766A3/ru active
-
1974
- 1974-06-06 AR AR254090A patent/AR202931A1/es active
- 1974-06-06 AR AR254091A patent/AR199966A1/es active
- 1974-09-26 NO NO743493A patent/NO148998C/no unknown
- 1974-12-18 ES ES433047A patent/ES433047A1/es not_active Expired
- 1974-12-18 ES ES433046A patent/ES433046A1/es not_active Expired
-
1975
- 1975-02-18 NO NO750535A patent/NO149139C/no unknown
- 1975-02-18 SU SU752106791A patent/SU667141A3/ru active
- 1975-02-19 SU SU752106125A patent/SU893130A3/ru active
- 1975-07-24 PH PH17410A patent/PH13110A/en unknown
- 1975-07-24 PH PH17409A patent/PH13325A/en unknown
- 1975-08-22 FR FR7526060A patent/FR2283146A1/fr active Granted
- 1975-08-22 FR FR7526059A patent/FR2279729A1/fr active Granted
-
1976
- 1976-07-23 AT AT544576A patent/AT360672B/de not_active IP Right Cessation
- 1976-07-23 AT AT544676A patent/AT353285B/de active
- 1976-10-15 JP JP51123737A patent/JPS5253841A/ja active Pending
- 1976-10-15 JP JP51123738A patent/JPS5257147A/ja active Pending
-
1977
- 1977-01-24 SE SE7700716A patent/SE445111B/xx not_active IP Right Cessation
- 1977-01-24 SE SE7700718A patent/SE431756B/xx not_active IP Right Cessation
- 1977-01-24 SE SE7700717A patent/SE436278B/xx not_active IP Right Cessation
- 1977-07-11 CA CA341,898A patent/CA1088931A/en not_active Expired
- 1977-07-11 CA CA341,897A patent/CA1088930A/en not_active Expired
-
1978
- 1978-07-27 SU SU782629453A patent/SU745362A3/ru active
-
1979
- 1979-03-15 KE KE2930A patent/KE2930A/xx unknown
- 1979-03-15 KE KE2931A patent/KE2931A/xx unknown
- 1979-03-15 KE KE2932A patent/KE2932A/xx unknown
- 1979-05-03 HK HK280/79A patent/HK28079A/xx unknown
- 1979-05-03 HK HK279/79A patent/HK27979A/xx unknown
- 1979-05-03 HK HK281/79A patent/HK28179A/xx unknown
- 1979-12-30 MY MY246/79A patent/MY7900246A/xx unknown
- 1979-12-30 MY MY245/79A patent/MY7900245A/xx unknown
- 1979-12-30 MY MY243/79A patent/MY7900243A/xx unknown
-
1980
- 1980-10-23 YU YU2706/80A patent/YU37316B/xx unknown
- 1980-10-23 YU YU2707/80A patent/YU36975B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR840005433A (ko) | 비사이클릭 화합물의 n-이미다졸릴 유도체의 제조방법 | |
| MX9203165A (es) | Derivados de succinimida y composicion farmaceutica que los contiene . | |
| GB1266642A (OSRAM) | ||
| GB1515414A (en) | 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins | |
| ES420386A1 (es) | Un procedimiento para preparar un pentanorprostaglandinas. | |
| ES433046A1 (es) | Un procedimiento para preparar productos intermedios de prostaglandinas. | |
| GB1459564A (en) | Alkylphenyl benzopyrans | |
| ES2109509T3 (es) | Procedimiento para la preparacion de beta-fenilisoserina y de sus analogos. | |
| ES408615A1 (es) | Procedimiento para la preparacion de 4-amino-3,5-dihalogenofenil - etanolaminas. | |
| GB1448458A (en) | 1,3-dioxan derivatives and pharmaceutical compositions thereof | |
| SE7901405L (sv) | Nya substituerade 2-fenylimino-imidazolidiner och deras syraadditionssaltersamt lekemedel innehallande dessa foreningar och forfarande for framstellning derav | |
| ES8801910A1 (es) | Un procedimiento para la preparacion de fenilalquil-2,3-dihidrobenzofuranos y los correspondientes dihidrobenzopiranos | |
| ES416865A1 (es) | Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15. | |
| SE7413025L (OSRAM) | ||
| GB1278348A (en) | Thiophen ethers and processes for preparing them | |
| ES524079A0 (es) | Procedimiento para preparar nuevos (3.2.0.) bicicloheptanonoxim-eteres | |
| SE8207294D0 (sv) | 1,4-tiazankarboxylsyraderivat, deras framstellning och anvendning och kompositioner vari dessa derivat ingar | |
| GR37765B (el) | Μεθοδος δια την παρασκευην υποκατεστημενων κινναμωμικων οξεων. | |
| GB1131126A (en) | 2-vinyl-1,4-dihydroquinazoline derivatives | |
| GB1378964A (en) | Pyridine derivatives | |
| ES438834A1 (es) | Un procedimiento para la preparacion de nuevos derivados de benzhidriloxi-alquilamina y de sus sales de adicion de aci- dos farmaceuticamente aceptables. | |
| GR35146B (el) | Μεθοδος παρασκευης οργανικων ενωσεων. | |
| ES430416A1 (es) | Procedimiento para preparar derivados de prostaglandina. | |
| IE38646L (en) | Morpholine and oxazine derivatives. | |
| ES406131A1 (es) | Procedimiento para la preparacion de acidos 4-(4-bifeni- lil)-butiricos y sus esteres. |